Abstract
The feasibility of single isocenter, multi-arc non-coplanar volumetric modulated arc therapy (VMAT) for multiple brain tumors was studied using an Elekta Synergy linear accelerator with an Agility multileaf collimator and a Monaco treatment planning system. Two VMAT radiosurgery plans consisting of a full arc and three half arcs were created with a prescribed dose of 20 Gy in a single fraction. After dose delivery to a phantom, ionization chambers and radiochromic films were used for dose measurement. The first VMAT radiosurgery plan had nine targets inside the phantom, and the doses were measured by the chambers at two different points and by the films on three sagittal and three coronal planes. The differences between the calculated dose and the dose measured by a Farmer ionization chamber and a pinpoint ionization chamber were <1.00% and <2.30%, respectively, and the average pass rates of gamma indices among the six planes under each of 3%/3 mm and 2%/2 mm criteria were 98.6% and 92.6%, respectively. The second VMAT radiosurgery plan was based on a clinical 14 brain metastases. Differences between calculated and film-measured doses were evaluated on two sagittal planes. The average pass rates of the gamma indices on the planes under each of 3%/3 mm and 2%/2 mm criteria were 97.8% and 88.8%, respectively. It was confirmed that single-isocenter, non-coplanar multi-arc VMAT radiosurgery for multiple brain metastases was feasible using Elekta Synergy with Agility and Monaco treatment planning systems. It was further shown that film dosimetry was accurately performed for a dose of up to nearly 25 Gy.
Keywords: radiosurgery, brain metastasis, single isocenter, VMAT, non-coplanar, film dosimetry, Agility, Monaco
INTRODUCTION
Linear-accelerator based stereotactic radiosurgery (SRS) has been widely employed for treating multiple brain tumors using conformal arc therapy (CAT) with multiple isocenters, where the treatment delivery time is roughly proportional to the number of tumors [1]. Prolonged treatment time may lead to tumor movement and thus reduced tumor control [2]. To decrease the SRS treatment time for multiple metastases, multi-isocenter volumetric modulated arc therapy (VMAT) has been used instead of multi-isocenter CAT [3, 4]. Wolff et al. compared SRS treatment deliveries between multi-isocenter single-arc VMAT and 5-arc CAT, demonstrating that VMAT provided much quicker delivery with increased mean dose to healthy brain [3]. Mayo et al. created non-coplanar multi-arc (2–3 arcs per isocenter) VMAT plans and treated 12 patients after validating dose distributions by using a 2D-array detector and films in a water-equivalent phantom [4].
In order to further shorten the treatment time of SRS for multiple metastases, single isocenter VMAT was evaluated [5–8]. Lagerwaard et al. compared single arc VMAT SRS with multiple isocenter multi-arc dynamic CAT, reporting that the treatment time was highly decreased and film measurements agreed with calculations [5]. They also studied single isocenter, coplanar 2-arc VMAT plans for three patients with multiple brain metastases, by way of simultaneous integrated boost with whole brain radiotherapy [6]. Meanwhile, Clark et al. reported that coplanar VMAT with a single isocenter had a significant planning limitation and that multi-arc non-coplanar VMAT with a single isocenter resulted in more favorable dose–volume histograms for challenging cases [7, 8]. However, the author focused on planning studies and did not show any dose verification results.
Recently, a new 160-leaf multileaf collimator (MLC) with a leaf width of 5 mm was developed by Elekta [9], but dosimetric aspects of VMAT SRS for multiple brain tumors using this MLC have not been published. The purpose of this paper was to study the feasibility of single isocenter, multi-arc non-coplanar VMAT SRS for multiple brain tumors using an Elekta Synergy linear accelerator with the 160-leaf MLC in terms of planning and dose verification.
MATERIALS AND METHODS
Single-isocenter non-coplanar VMAT radiosurgery plans were created with a full arc (couch angle: 0°) and three half arcs (couch angles: ± 45° and 90°) using Monaco ver. 3.30 (Elekta AB, Stockholm, Sweden) based on X-ray Voxel Monte Carlo (XVMC) and constraint optimization algorithms with biological cost functions. A photon energy of 6 MV was employed throughout this study. The dose calculation grid size and the calculated dose statistics were set to 2 mm and 0.5% (normalized standard deviation) per plan, respectively.
The first VMAT radiosurgery plan employed a nine spherical target model created inside an I'mRT phantom (IBA Dosimetry, Schwarzenbruck, Germany). The nine spherical targets had diameters ranging from 5–40 mm located at the center and at the eight corners of a virtual cube with an 80 mm side length. The center of the cube and the center of the phantom were coincident. Figure 1 indicates the positions of the nine targets as well as the beam arrangement of the plan. A dose of 20 Gy in a single fraction was prescribed for 95% of the planning target volume (PTV), and the isocenter was positioned at the center of the phantom. The Elekta Synergy linear accelerator with an Agility MLC (Elekta AB, Stockholm, Sweden) installed at the Radiation Therapy Training Center (RTTC) of Toshiba Medical Systems (Nasu, Tochigi, Japan) was used. The dose delivery for the nine-target plan was verified using ionization chambers and Gafchromic EBT3 films (Ashland Inc., Covington, USA). Point doses were measured at the isocenter (0 mm, 0 mm, 0 mm) and at the center of the largest target (40 mm, −40 mm, −40 mm) using 0.015 cm3 pinpoint and 0.6 cm3 Farmer ionization chambers (Type N31014 and Type N30013, PTW, Freiburg, Germany). Absolute dose distributions were measured using films on three parallel planes (either sagittal or coronal), including isocentric planes with a film interval of 40 mm. Prior to the film measurement, a dose ranging from 0–25 Gy was delivered to the film for calibration, where the films were oriented perpendicular to the beam axis and placed between two solid water phantoms, each with a thickness of 10 cm. The source-to-film distance was 100 cm.
The second VMAT radiosurgery plan was based on clinical 14 brain metastases (14-mets) having the same arc beam geometry as the nine-target plan, except for the plan isocenter being positioned at the gravitational center of the 14 targets. The target volume was 0.12 cm3 on average, and ranged from 0.03–0.71 cm3. Figure 2 shows the target positions and the beam arrangement of this plan. A dose (D95) of 20 Gy in a single fraction was prescribed for 95% of each of the 14 PTVs with quadratic overdose constraints. For comparison, the same D95 dose was also prescribed for the entire 14 PTVs. The doses outside each PTV were constrained to 9, 6 and 2.5 Gy at a distance of 3, 6 and 20 mm from each PTV surface, respectively. Paddick's conformity index (PCI) and gradient index (PGI) were calculated for the 14-mets plan as a function of the target volume [10, 11].
To verify the 14-mets plan, film dosimetry was performed again by using the I'mRT phantom and the Gafchromic EBT3 films. With the isocenter and the center of the phantom coincident, films were positioned on two sagittal planes at −20 mm and −45 mm from the isocenter, where the dosimetry for six and four targets were evaluated, respectively.
The films were scanned in landscape orientation [using an ES-8500 (EPSON, Nagano, Japan) scanner with a spatial resolution of 75 dpi] after 15 h of irradiation with warm-up scans repeated three times. The scanned images were saved in 48-bit RGB tiff format. The green channel of the images was analyzed using SNC Patient software (Sun Nuclear, Melbourne, Florida, USA). For absolute dose distributions, gamma analyses under 3%/3 mm and 2%/2 mm criteria, with global percent differences were used with a dose threshold of 30% of the maximum measured dose on each film plane.
RESULTS
Figure 3a and b show dose–volume histograms for the 14-mets plan, where a D95 dose of 20 Gy in a single fraction was prescribed for (Fig. 3a) each of the 14 PTVs and (Fig. 3b) the entire volumes of the 14 PTVs. As anticipated, the variation of D95 doses among the 14 PTVs was smaller when the dose was prescribed for each PTV. Further investigation would be required to reduce this variation.
Table 1 indicates the point doses measured by the ionization chambers along with the percentage dose differences between the Monaco calculations and the chamber measurements for the nine-target plan. The dose differences between the calculations and the measurements using the Farmer and the pinpoint ionization chambers were <1.00% and <2.30%, respectively.
Table 1.
Position (mm) | Target diameter (mm) | Chamber | Measurement (Gy) | Calculation (Gy) | Difference |
---|---|---|---|---|---|
(0, 0, 0) | 20 | Farmer pinpoint | 22.89 24.73 |
22.68 24.19 |
0.93% 2.23% |
(40, −40, −40) | 40 | Farmer pinpoint | 21.59 21.11 |
21.75 21.54 |
−0.74% −2.00% |
Figure 4 shows a plot of net optical density measured using the scanner green channel (16-bit depth) as a function of delivered doses, which agrees with the results reported by Casanova Borca et al. [12]. Table 2 indicates the pass rates of the absolute dose gamma analyses for the nine-target plan using the EBT3 films on six different planes. Average pass rates for the six planes under each of the 3%/3 mm and 2%/2 mm criteria were 98.6% (range, 99.4–97.6%) and 92.6% (range, 95.3–86.5%), respectively.
Table 2.
Sagittal film position (mm) | 3%/3 mm (2%/2 mm) | Coronal film position (mm) | 3%/3 mm (2%/2 mm) |
---|---|---|---|
+40 | 98.8% (95.3%) | +40 | 99.4% (94.6%) |
0 | 99.2% (94.1%) | 0 | 98.2% (86.5%) |
−40 | 97.6% (90.5%) | −40 | 98.6% (94.3%) |
A global percent difference criterion was employed with a dose threshold of 30% of the maximum measured dose on each film plane, where each film position was indicated as a distance from the isocenter plane.
For the 14-mets plan, average pass rates on the two sagittal planes (−20 mm and −45 mm from the isocenter) under each of the 3%/3 mm and 2%/2 mm criteria were 97.8% (range, 99.1–96.5%) and 88.8% (range, 90.1–87.4%), respectively. Figure 5 indicates the film dosimetry results on a sagittal plane at −20 mm for the 14-mets plan. The absolute film dosimetry agrees well with the Monaco calculation with a visible but small discrepancy detected at the left peak in Fig. 5d, the cause being unknown. The delivery time of the 14-mets plan was 40 min including couch rotation.
DISCUSSION
Figure 6 shows plots of the PCI for the 14-mets plan as a function of the target volume, where D95 was prescribed for each of the PTVs (marked with filled circles) and for the entire PTVs (marked with X's). It was found that the PCIs for two targets were significantly lower than for the others (marked with open circle), possibly resulting from an exceptionally short distance between the two targets (1 cm). Stanley et al. showed that PCI increased as the tumor volume increased, reaching a saturation value of 0.7 [13]. Our results indicate that the PCI is >0.5 when the tumor volume is >0.1 cm3, and the PCI reaches nearly 0.7 when the tumor volume approaches 1.0 cm3, suggesting that the 5 mm width MLC may be sufficiently minute for small targets with diameters of <1 cm when multi-arc non-coplanar VMAT SRS is adopted.
Figure 7 demonstrates plots of the PGI of the 14-mets plan as a function of the target volume, where D95 was prescribed for each of the PTVs (marked with filled circles) and for the entire PTVs (marked with X's). Again, PGIs for two targets were significantly lower than for the others (marked with open circle), possibly resulting from an exceptionally short distance between the two targets (1 cm). The dose gradient tends to decrease as the target volume increases [14].
In Table 1, the cause of the larger dose discrepancy in the pinpoint chamber measurement may be due to statistical uncertainty of the Monte Carlo calculation. In other words, an isotropic dose grid of 2 mm results in only a few grids inside the pinpoint chamber volume, whereas the Farmer chamber volume has dose grids >50.
In Table 2, the pass rate of 2%/2 mm at the coronal film position 0 mm is worse than the pass rates on other planes. The plane had one target with a much larger low-dose area. If the dose threshold is changed from 30% to 50% of the maximum measured dose on the plane, the pass rate under the 2%/2 mm criteria is improved from 86.5% to 96.7%.
CONCLUSION
In conclusion, it was confirmed that dose verification of single-isocenter, non-coplanar multi-arc VMAT radiosurgery for multiple brain metastases is feasible using an Elekta Synergy with Agility and Monaco treatment-planning systems. It was further shown that film dosimetry was accurately performed for a dose of up to nearly 25 Gy.
CONFLICT OF INTEREST
S.O. has a consulting contract with Elekta KK.
REFERENCES
- 1.Boehling NS, Chang EL, Ma Lijun, et al. Stereotactic radiosurgery for brain metastases: current status and future directions. J Radiat Oncol. 2012;1:245–53. [Google Scholar]
- 2.Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004;59:242–9. doi: 10.1016/j.ijrobp.2004.01.004. [DOI] [PubMed] [Google Scholar]
- 3.Wolff HA, Wagner DM, Christiansen H, et al. Single fraction radiosurgery using Rapid Arc for treatment of intracranial targets. Radiat Oncol. 2010;5:77. doi: 10.1186/1748-717X-5-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mayo CS, Ding L, Addesa A, et al. Initial experience with volumetric IMRT (RapidArc) for intracranial stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010;78:1457–66. doi: 10.1016/j.ijrobp.2009.10.005. [DOI] [PubMed] [Google Scholar]
- 5.Lagerwaard FJ, Verbakel WFAR, van der Hoorn E, et al. Volumetric modulated arc therapy (RapidArc) for rapid, non-invasive stereotactic radiosurgery of multiple brain metastases. Int J Radiat Oncol Biol Phys. 2008;72:S530. [Google Scholar]
- 6.Lagerwaard FJ, van der Hoorn EAP, Verbakel WFAR, et al. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2009;75:253–9. doi: 10.1016/j.ijrobp.2009.03.029. [DOI] [PubMed] [Google Scholar]
- 7.Clark GM, Popple RA, Young PE, et al. Feasibility of single-isocenter volumetric modulated arc radiosurgery for treatment of multiple brain metastases. Int J Radiat Oncol Biol Phys. 2010;76:296–302. doi: 10.1016/j.ijrobp.2009.05.029. [DOI] [PubMed] [Google Scholar]
- 8.Clark GM, Popple RA, Prendergast BM, et al. Plan quality and treatment planning technique for single isocenter cranial radiosurgery with volumetric modulated arc therapy. Pract Radiat Oncol. 2012;2:306–13. doi: 10.1016/j.prro.2011.12.003. [DOI] [PubMed] [Google Scholar]
- 9.Cosgrove VP, Thomas MDR, Weston SJ, et al. Physical characterization of a new concept design of an Elekta radiation head with integrated 160-leaf multi-leaf collimator. Int J Radiat Oncol Biol Phys. 2009;75:S722–3. [Google Scholar]
- 10.Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg. 2000;93(Suppl 3):219–22. doi: 10.3171/jns.2000.93.supplement. Technical note. [DOI] [PubMed] [Google Scholar]
- 11.Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 2006;105(Suppl):194–201. doi: 10.3171/sup.2006.105.7.194. [DOI] [PubMed] [Google Scholar]
- 12.Casanova Borca V, Pasquino M, Russo G, et al. Dosimetric characterization and use of GAFCHROMIC EBT3 film for IMRT dose verification. J Appl Clin Med Phys. 2013;14:158–71. doi: 10.1120/jacmp.v14i2.4111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Stanley J, Breitman K, Dunscombe P, et al. Evaluation of stereotactic radiosurgery conformity indices for 170 target volumes in patients with brain metastases. J Appl Clin Med Phys. 2011;12:245–53. doi: 10.1120/jacmp.v12i2.3449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ohtakara K, Hayashi S, Hoshi H. Dose gradient analyses in linac-based intracranial stereotactic radiosurgery using Paddick's gradient index: consideration of the optimal method for plan evaluation. J Radiat Res. 2011;52:592–9. doi: 10.1269/jrr.11005. [DOI] [PubMed] [Google Scholar]